October 2019 “Only Option” for Drug Price Revision Tied to Sales Tax Hike: New FPMAJ Chief

FPMAJ Chairman Isao Teshirogi The new leader of the umbrella organ of Japanese pharma trade groups has expressed the industry’s opposition to a two-step price tweak in 2019 that the government eyes for the planned consumption tax hike in October...read more